Vifor Pharma AG Logo

Vifor Pharma AG

VIFN | SW

Overview

Corporate Details

ISIN(s):
CH0364749348
LEI:
529900KO6CN2D9OE1F19
Country:
Switzerland
Address:
Rechenstrasse 37, 9014 St. Gallen
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CSL Vifor is a global specialty biotechnology company focused on iron deficiency, nephrology, and rare diseases. A pioneer and global leader in iron-based therapies, the company develops, manufactures, and markets pharmaceutical products to address significant unmet medical needs. Its core therapeutic areas include iron deficiency anemia in conditions such as heart failure, kidney disease, gastroenterology, and women's health. In partnership with its joint company, Vifor Fresenius Medical Care Renal Pharma, CSL Vifor has a strong and growing presence in treating the full spectrum of kidney disease. The company's business model emphasizes strategic global partnering, in-licensing, and commercializing innovative therapies, with a presence in over 100 countries.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Vifor Pharma AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Vifor Pharma AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Vifor Pharma AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-03-09 N/A Executive member Sell None 4,335,210.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,951,125.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,851,300.00 CHF
2022-03-09 N/A Executive member Sell None 1,535,160.00 CHF
2022-03-09 N/A Non-Executive member Sell None 1,450,515.00 CHF
2022-03-09 N/A Executive member Sell None 920,205.00 CHF
2022-03-09 N/A Executive member Sell None 530,310.00 CHF
2022-03-09 N/A Non-Executive member Sell None 382,140.00 CHF
2022-03-09 N/A Non-Executive member Sell None 330,495.00 CHF
2022-03-09 N/A Executive member Sell None 287,925.00 CHF

Peer Companies

Company Country Ticker View
UCB Logo
UCB
A biopharmaceutical firm developing therapies for severe neurological and immunological diseases.
Belgium UCB
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Specialty vaccine developer for travelers and infectious diseases like chikungunya.
France VLA
VENTURE LIFE GROUP PLC Logo
Develops and distributes consumer self-care products for the ageing population worldwide.
United Kingdom VLG
Vetoquinol SA Logo
Develops and distributes veterinary drugs and products for livestock and companion animals globally.
France VETO
Virbac Logo
A pharmaceutical company developing animal health solutions for vets, farmers, and pet owners worldwide.
France FR000
ViroGates A/S Logo
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
Denmark VIRO
Vistin Pharma Logo
A leading global producer of Metformin API for the international pharmaceutical industry.
Norway VISTN
Vita 34 AG Logo
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
Germany V3V